MS in the News: MUCH to say about CCSVI and other MS News

Stu's Views and MS Related News

A product of:

"Providing You with 'MS Views and News', is what we do"

Today is: February 11, 2010

Today's e-newsletter will reach more than 9000 readers in (66) Countries

In this week's edition there is much to read about the CCSVI research now underway in many locations and is the hottest topic currently amongst those affected by Multiple Sclerosis. Additional topics include: Patient Stories, Prescription (Rx) Assistance, Ampyra information, Brain studies, Tysabri News, and more...

Scroll to see the hyper-links available for easy reading of each article

==================================================

This week's ( 23 ) postings:

• Multiple Sclerosis related - Buffalo CCSVI Study R... A Wheelchair Kamikaze report
• Another Great article from Wheelchair Kamikaze "
• First Blinded Study of Venous Insufficiency (CCSVI... CCSVI - First Study revealed
• Neutralizing Antibodies to Interferon Beta That Pe... Neutralizing Antibodies
• PIVOTAL MS NEWS - Leaders from National MS Society... CCSVI and the National MS Society
• Comments on the National Post articles on Dr Zambo... CCSVI
• SHE learned she had multiple sclerosis nearly 12 ... A Patient's Story
• MS Related: Patient Prescription (Rx) Assistance ... Prescription (Rx) Assistance
• Star skier Jimmie Heuga dies - He helped thousands... A pioneer leaves us
• Multiple Sclerosis Experts Join Biogen Idec's Rese... NMSS Medical expert joins Biogen
• My Friend, "The Wheelchair Kamikaze" needs your vo... An MS Patient needs you vote
• Oral drugs to treat multiple sclerosis could becom... Oral Meds
• 'Liberation' MS treatment scientist welcomes skept... CCSVI
• New Study Finds Specialized Support Programs Can I... Benefitting Support Programs
• Multiple Sclerosis: Blacks Have More Severe Sympto... Severe Symptoms affect some more than others
• Research on the Blood-Brain Barrier in MS BBB Research

• Biogen Plans First Study For Earlier Use Of MS Dru... A New Tysabri Study
• AMPYRA for Multiple Sclerosis - Pricing that will... AMPYRA pricing and assistance
• FDA warns of brain risks with frequent Tysabri use... Tysabri News
• Interview-based study describes how MS affects eng... Study describes how MS affects what we do
• Studying MS. Autoimmune or Vascular ? The BNAC - C... CCSVI
• New Multiple Sclerosis treatment may end with Utah... A Patient's Story
• Multiple Sclerosis Gait issues - a two-part webina... NMSS discusses Gait (walking) Issues

Consider a donation to MS Views and News, to help us provide educational information like this e-newsletter, to those affected by MS

Find me or MS Views and News on Facebook

Have questions or comments? write to: stuart@msviewsandnews.org

Have a Great week everybody.

Best Regards,

Stuart Schlossman

========================================================

e-Newsletter Disclaimer:

***Editor's Note: The intent of this newsletter is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

========================================================